Rousseau A, Marquet P, Comby F, Buxeraud J, Raby C, Lachâtre G
Department of Biophysics-Informatique, Faculty of Pharmacy, University of Limoges, France.
J Chromatogr B Biomed Sci Appl. 1997 May 23;693(1):93-100. doi: 10.1016/s0378-4347(97)00052-2.
A new sensitive method for the quantitative determination of imipramine and desipramine in single rat thyroids using gas chromatography-mass spectrometry with selected ion monitoring, after enzymatic hydrolysis and liquid-liquid extraction has been developed. The technique was deemed suitable for microanalysis of single rat thyroids and for other solid tissues, using smaller sample sizes than usually required for traditional determination methods. The quantification was linear from 10 to 200 nmol/l (i.e., from 0.25 to 5 microg/g) for imipramine and from 100 nmol/l to 2000 nmol/l (i.e., from 2.4 to 47 microg/g) for desipramine, and the limits of detection (less than 25 ng/g tissue for both compounds) were better than those previously reported. Recoveries, repeatability and reproducibility of this technique were satisfactory. It has been successfully applied in a preliminary study of the concentration-time profiles of imipramine and desipramine in the thyroid of rats treated with either of these drugs.
已开发出一种新的灵敏方法,用于在酶促水解和液液萃取后,采用气相色谱 - 质谱联用选择离子监测技术对单只大鼠甲状腺中的丙咪嗪和地昔帕明进行定量测定。该技术被认为适用于单只大鼠甲状腺的微量分析以及其他固体组织,使用的样本量比传统测定方法通常所需的更小。丙咪嗪的定量范围为10至200 nmol/L(即0.25至5 μg/g),地昔帕明的定量范围为100 nmol/L至2000 nmol/L(即2.4至47 μg/g),两种化合物的检测限(均低于25 ng/g组织)优于先前报道的结果。该技术的回收率、重复性和再现性令人满意。它已成功应用于对用这两种药物之一治疗的大鼠甲状腺中丙咪嗪和地昔帕明浓度 - 时间曲线的初步研究。